EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cell-based treatments of lung diseases: overview and outlook

A M van der Does, L V Schledorn, R Olmer

Advanced Drug Delivery Reviews · 2025-12 · 227 · 115712

DOI: 10.1016/j.addr.2025.115712 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2025-12. Verfasst von A M van der Does und 2 weiteren Autor:innen. Beteiligte Einrichtung: PulmoScience Lab, Department of Pulmonology, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Lung Diseases, Cell- and Tissue-Based Therapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Center for Lung Research, Bundesministerium für Forschung, Technologie und Raumfahrt.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic lung diseases (CLD), including chronic obstructive pulmonary disease (COPD), pulmonary fibrosis and pulmonary hypertension, represent a significant health burden worldwide and their incidence is steadily increasing. Specifically, COPD and lung fibrosis lead to progressive tissue loss, particularly in the alveolar region, and can currently mainly be treated symptomatically, with some therapies slowing down progression. Regenerative cell therapy offers promising approaches to repair and restore permanently damaged lung tissue, focusing on different cell types such as epithelial, stromal, endothelial and pluripotent stem cells. Despite positive results in preclinical studies and initial clinical trials, large successes are lagging behind. This shows that there is still a considerable need for further research into e.g. optimal conditions, including cell sources and administration methods in humans. Challenges such as successful translation of beneficial strategies in animal models, safety risks of new strategies and the control of cell localization need to be addressed in more detail. Future research approaches should therefore support the identification of suitable cell types, the improvement of cell protection strategies and the development of predictable human models to enable the successful clinical application of regenerative cell therapy in CLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung DiseasesCell- and Tissue-Based TherapyHumansAnimals

Stichwörter der Autor:innen

Cell therapyChronic lung diseasePluripotent stem cells;RegenerationRepairTissue

Autor:innen und Institutionen

  • PulmoScience Lab, Department of Pulmonology, Leiden University Medical Center, Leiden, the Netherlands.
  • Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Clinic for Cardiothoracic-, Transplantation and Vasuclar Surgery, Biomedical Research in Endstage and Obstructive Lung Disease (BREATH), Ger…

Förderung

  • German Center for Lung Research
  • Bundesministerium für Forschung, Technologie und Raumfahrt

Zitieren

APA

van der Does, A. M., V Schledorn, L., & Olmer, R. (2025). Cell-based treatments of lung diseases: overview and outlook. Advanced Drug Delivery Reviews, 227, 115712. https://doi.org/10.1016/j.addr.2025.115712

Vancouver

van der Does AM, V Schledorn L, Olmer R. Cell-based treatments of lung diseases: overview and outlook. Advanced Drug Delivery Reviews. 2025;227:115712. doi:10.1016/j.addr.2025.115712

BibTeX
@article{vanderDoes2025,
  author = {van der Does, A M and V Schledorn, L and Olmer, R},
  title = {Cell-based treatments of lung diseases: overview and outlook},
  journal = {Advanced Drug Delivery Reviews},
  year = {2025},
  volume = {227},
  pages = {115712},
  doi = {10.1016/j.addr.2025.115712}
}
Kostenlos starten →